Bdnf/nf-kappa b signaling in the neurobiology of depression

Current Pharmaceutical Design

dc.creatorCaviedes, Ariel
dc.creatorLafourcade, Carlos
dc.creatorSoto, Claudio
dc.creatorWyneken-Hempel, Inge Ursula
dc.creatorKhoury, M
dc.date2018-11-29T15:36:48Z
dc.date2022-07-07T15:54:21Z
dc.date2014
dc.date2018-11-29T15:36:48Z
dc.date2022-07-07T15:54:21Z
dc.date2017
dc.date.accessioned2023-08-22T09:29:34Z
dc.date.available2023-08-22T09:29:34Z
dc.identifier1140108
dc.identifier1140108
dc.identifierhttps://hdl.handle.net/10533/228517
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8336476
dc.descriptionBackground: Mood disorders, consisting of unipolar and bipolar depression, are complex diseases characterized by depressed mood and anhedonia. These core symptoms are accompanied in a varying manner by anxiety, several neurovegetative symptoms and cognit
dc.descriptionRegular
dc.descriptionFONDECYT
dc.descriptionFONDECYT
dc.languageeng
dc.relationhandle/10533/111556
dc.relationhandle/10533/111541
dc.relationhandle/10533/108045
dc.relationhttps://uthealth.influuent.utsystem.edu/en/publications/bdnfnf-%CE%BAb-signaling-in-the-neurobiology-of-depression
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleBdnf/nf-kappa b signaling in the neurobiology of depression
dc.titleCurrent Pharmaceutical Design
dc.typeArticulo
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución